Jingli Zhang

3.4k total citations
80 papers, 2.4k citations indexed

About

Jingli Zhang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Jingli Zhang has authored 80 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 25 papers in Molecular Biology and 19 papers in Oncology. Recurrent topics in Jingli Zhang's work include Occupational and environmental lung diseases (23 papers), Pleural and Pulmonary Diseases (8 papers) and Cancer Research and Treatments (6 papers). Jingli Zhang is often cited by papers focused on Occupational and environmental lung diseases (23 papers), Pleural and Pulmonary Diseases (8 papers) and Cancer Research and Treatments (6 papers). Jingli Zhang collaborates with scholars based in China, United States and New Zealand. Jingli Zhang's co-authors include Raffit Hassan, Ira Pastan, Masanori Onda, Mitchell Ho, Anish Thomas, Seth M. Steinberg, Husam M. Abu‐Soud, Dipak Ghosh, Markku Miettinen and Maureen Sampson and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Jingli Zhang

74 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingli Zhang China 27 770 744 571 507 361 80 2.4k
Paula A. Videira Portugal 30 279 0.4× 1.6k 2.1× 391 0.7× 925 1.8× 284 0.8× 127 2.9k
Yili Wang China 27 203 0.3× 862 1.2× 690 1.2× 550 1.1× 239 0.7× 121 2.7k
Subhankar Chakraborty United States 28 387 0.5× 1.1k 1.5× 963 1.7× 444 0.9× 67 0.2× 75 2.6k
Uddalak Bharadwaj United States 26 335 0.4× 1.1k 1.5× 1.1k 1.9× 691 1.4× 147 0.4× 57 2.9k
Jennifer L. Hsu United States 23 402 0.5× 1.5k 2.0× 1.3k 2.2× 471 0.9× 89 0.2× 55 3.2k
Yoshinori Inagaki Japan 28 388 0.5× 1.1k 1.4× 416 0.7× 238 0.5× 76 0.2× 125 2.7k
Akinobu Gotoh Japan 32 616 0.8× 1.5k 2.0× 916 1.6× 229 0.5× 279 0.8× 189 3.6k
Stefano Fiore United States 26 231 0.3× 1.2k 1.6× 452 0.8× 972 1.9× 76 0.2× 94 3.1k

Countries citing papers authored by Jingli Zhang

Since Specialization
Citations

This map shows the geographic impact of Jingli Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingli Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingli Zhang more than expected).

Fields of papers citing papers by Jingli Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingli Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingli Zhang. The network helps show where Jingli Zhang may publish in the future.

Co-authorship network of co-authors of Jingli Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Jingli Zhang. A scholar is included among the top collaborators of Jingli Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingli Zhang. Jingli Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Venugopalan, Abhilash, Jingli Zhang, Nishanth Ulhas Nair, et al.. (2024). Persistence of activated anti‐mesothelin hYP218 chimeric antigen receptor T cells in the tumour is associated with efficacy in gastric and colorectal carcinomas. Clinical and Translational Medicine. 14(11). e70057–e70057. 3 indexed citations
2.
Li, Nana, Jing Tao, Jingli Zhang, Zhen Liu, & Ping Yu. (2023). A novel mutation in a CARD14‐associated papulosquamous eruption. Pediatric Dermatology. 40(4). 706–709. 2 indexed citations
3.
Tomar, Sakshi, Jingli Zhang, Manakamana Khanal, et al.. (2022). Development of Highly Effective Anti-Mesothelin hYP218 Chimeric Antigen Receptor T Cells With Increased Tumor Infiltration and Persistence for Treating Solid Tumors. Molecular Cancer Therapeutics. 21(7). 1195–1206. 31 indexed citations
4.
Zhang, Jingli, et al.. (2022). Design of Cyclic Peptide-Based Nanospheres and the Delivery of siRNA. International Journal of Molecular Sciences. 23(20). 12071–12071. 9 indexed citations
5.
Jiang, Qun, Azam Ghafoor, Idrees Mian, et al.. (2020). Enhanced efficacy of mesothelin-targeted immunotoxin LMB-100 and anti–PD-1 antibody in patients with mesothelioma and mouse tumor models. Science Translational Medicine. 12(550). 35 indexed citations
6.
7.
Wang, Lihong, et al.. (2019). Application practice of case surveillance system for healthcare-associated infections. Zhonghua yiyuan guanli zazhi. 35(5). 395–397. 1 indexed citations
8.
Khanna, Swati, Francis Mussai, Anish Thomas, et al.. (2018). Tumor-Derived GM-CSF Promotes Granulocyte Immunosuppression in Mesothelioma Patients. Clinical Cancer Research. 24(12). 2859–2872. 43 indexed citations
9.
Wang, Fang, et al.. (2018). Effect of Lanthanum Carbonate on All-Cause Mortality in Patients Receiving Maintenance Hemodialysis: a Meta-Analysis of Randomized Controlled Trials. Kidney & Blood Pressure Research. 43(2). 536–544. 12 indexed citations
10.
Zhang, Jingli, Swati Khanna, Qun Jiang, et al.. (2016). Efficacy of Anti-mesothelin Immunotoxin RG7787 plus Nab-Paclitaxel against Mesothelioma Patient–Derived Xenografts and Mesothelin as a Biomarker of Tumor Response. Clinical Cancer Research. 23(6). 1564–1574. 30 indexed citations
11.
Khanna, Swati, Anish Thomas, Daniel Abate‐Daga, et al.. (2016). Malignant Mesothelioma Effusions Are Infiltrated by CD3+ T Cells Highly Expressing PD-L1 and the PD-L1+ Tumor Cells within These Effusions Are Susceptible to ADCC by the Anti–PD-L1 Antibody Avelumab. Journal of Thoracic Oncology. 11(11). 1993–2005. 78 indexed citations
12.
Mazor, Ronit, Jingli Zhang, Laiman Xiang, et al.. (2015). Recombinant Immunotoxin with T-cell Epitope Mutations That Greatly Reduce Immunogenicity for Treatment of Mesothelin-Expressing Tumors. Molecular Cancer Therapeutics. 14(12). 2789–2796. 33 indexed citations
13.
Deng, Li, Jingli Zhang, Xudong Zhang, et al.. (2014). A Distinct Expression Pattern of Cyclin K in Mammalian Testes Suggests a Functional Role in Spermatogenesis. PLoS ONE. 9(7). e101539–e101539. 16 indexed citations
14.
Espley, Richard V., Christine A. Butts, William A. Laing, et al.. (2013). Dietary Flavonoids from Modified Apple Reduce Inflammation Markers and Modulate Gut Microbiota in Mice. Journal of Nutrition. 144(2). 146–154. 153 indexed citations
15.
Weldon, John E., Laiman Xiang, Jingli Zhang, et al.. (2012). A Recombinant Immunotoxin against the Tumor-Associated Antigen Mesothelin Reengineered for High Activity, Low Off-Target Toxicity, and Reduced Antigenicity. Molecular Cancer Therapeutics. 12(1). 48–57. 77 indexed citations
16.
Zhang, Yujian, Oleg Chertov, Jingli Zhang, Raffit Hassan, & Ira Pastan. (2011). Cytotoxic Activity of Immunotoxin SS1P Is Modulated by TACE-Dependent Mesothelin Shedding. Cancer Research. 71(17). 5915–5922. 39 indexed citations
17.
Hassan, Raffit, Alan T. Remaley, Maureen Sampson, et al.. (2006). Detection and Quantitation of Serum Mesothelin, a Tumor Marker for Patients with Mesothelioma and Ovarian Cancer. Clinical Cancer Research. 12(2). 447–453. 220 indexed citations
18.
Dall’Acqua, William F., Melissa Damschroder, Jingli Zhang, et al.. (2005). Antibody humanization by framework shuffling. Methods. 36(1). 43–60. 50 indexed citations
19.
Zhang, Jingli, Hongying Zhang, Hong Bu, et al.. (2003). Comparison between expression of Ki-67 and PCNA in breast carcinoma. Experimental Pathology. 19(1). 70–72.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paula A. Videira Breakdown of academic impact, for papers by Yili Wang Breakdown of academic impact, for papers by Subhankar Chakraborty Breakdown of academic impact, for papers by Uddalak Bharadwaj Breakdown of academic impact, for papers by Jennifer L. Hsu Breakdown of academic impact, for papers by Yoshinori Inagaki Breakdown of academic impact, for papers by Akinobu Gotoh Breakdown of academic impact, for papers by Stefano Fiore
Rankless by CCL
2026